by [email protected] | Mar 3, 2022 | Endocrine, Publication
Abstract Introduction Humulin R U-500 (U-500R) utilization has increased in the past few years, raising concerns as U-500R is indicated only for patients requiring > 200 units of insulin. Thus, evidence of dispensed total daily dose (dTDD) > 200 units of prior...
by [email protected] | Nov 5, 2021 | Endocrine, Publication
Authors: Jieling Chen, Sujana Borra, Ludi Fan, Ahong Huang, Dhiren Patel, Rattan Juneja Abstract Introduction: A dedicated Humulin R U-500 (U-500R) prefilled disposable insulin pen (KwikPen) became available in 2016, yet limited evidence exists on...
by [email protected] | Jul 20, 2021 | Endocrine, Publication
Abstract Objectives: Severely insulin-resistant type 2 diabetes (T2D) patients face unique treatment challenges. Humulin R U-500 (U-500R) as insulin monotherapy with both basal/bolus properties addresses these challenges but remains understudied. This...
by [email protected] | May 7, 2020 | Cardiovascular, Endocrine, Publication
Abstract Authors: Gregory Y H Lip, Allison V Keshishian, Amiee L Kang, Xiaoyan Li, Amol D Dhamane, Xuemei Luo, Neeraja Balachander, Lisa Rosenblatt, Jack Mardekian, Anagha Nadkarni, Xianying Pan, Manuela Di Fusco, Alessandra B Garcia Reeves, Huseyin Yuce, Steven B...
by [email protected] | Jun 14, 2019 | Endocrine, Publication
Abstract Authors: Fang L Zhou, Charlie Nicholls, Lin Xie, Yuexi Wang, Neel Vaidya, Luigi F Meneghini Introduction: Type 2 diabetes (T2D) is characterized by worsening pancreatic β-cell function often requiring treatment escalation with oral antidiabetic drugs (OADs),...
by [email protected] | May 16, 2019 | Endocrine, Publication
Abstract Authors: Zhou FL, Xie L, Pan C, Wang Y, Vaidya N, Ye F, Preblick R, Meneghini L. This study examines the relationship between glycated haemoglobin (A1C) levels and treatment persistence with, or time to discontinuation of, basal insulin in patients with type...
